Dementia Research: Where are we now?

Dale Goldhawk, Vice Chair of ADI, takes a personal view on psychosocial dementia research. It’s a sad fact that, to date, not much in the Alzheimer research world has been considered “groundbreaking”. The development of cholinesterase inhibitors certainly marked some progress but, while those medications can help with symptoms, they bear no resemblance to an …

Back To Blog